Sophie holds a PhD in Oncology and has a research background in tumor biology and experimental cancer models. Her work includes experience with targeted therapies and radiotherapy in animal tumor models, as well as expertise in immunohistochemistry.
At Redoxis, Sophie leads in vivo studies, overseeing study design, execution, and data analysis across a range of preclinical models. Her background in oncology and tissue-based analyses supports projects investigating disease mechanisms and therapeutic interventions.
Her work contributes to preclinical research programs within oncology, inflammation, and immune-mediated diseases.
